Somatic Symptom Disorder vs Bodily Distress Disorder: DSM-5-TR and ICD-11
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Somatic symptom disorder (SSD) in DSM-5-TR and bodily distress disorder (BDD) in ICD-11 are overlapping clinical concepts concerning persistent, distressing physical symptoms and a person's clinically significant attention or responses to them. Both recognize genuine bodily experiences. They use distinct diagnostic requirements and do not have a one-to-one conversion. Understanding the differences matters when reading medical records, comparing research, or seeking treatment. The governing sources are the American Psychiatric Association, the World Health Organization ICD-11 clinical guidance, and direct international comparative research.
The decisive distinctions involve how long the symptom state has persisted, the thresholds for distress and impaired functioning, how excessiveness of symptom-related concern is established, the role of healthcare consultations, and whether another psychiatric disorder better explains the presentation. Neither diagnosis requires symptoms to be medically unexplained, proves a psychological cause, or permits clinicians to dismiss new symptoms. A physical illness and a somatic-distress diagnosis can coexist. APA clinical definition; WHO CDDR.
What is somatic symptom disorder in DSM-5-TR?
Somatic symptom disorder is classified in the DSM-5-TR family of Somatic Symptom and Related Disorders. Its first component is one or more somatic symptoms that are distressing or significantly disrupt everyday life. Its second is excessive thoughts, feelings, or behaviors related to symptoms or health concerns. Clinicians assess at least one of three patterns: disproportionate and persistent thoughts about symptom seriousness, persistently high health- or symptom-related anxiety, or excessive time and energy devoted to the symptoms or health concerns. The symptomatic state is persistent, typically longer than six months, although a single symptom need not be constant throughout. APA; DSM.
A physical symptom can be pain, nausea, fatigue, dizziness, gastrointestinal disturbance, shortness of breath, palpitations, or another experience. The symptom can arise alongside a known disease, after an illness, or without a clearly established explanation. The diagnostic significance comes from the complete pattern of symptoms and symptom-focused response, assessed in clinical context. Serious medical illness often warrants substantial vigilance and repeated contact with healthcare; those actions alone cannot establish that attention is excessive. A clinical diagnosis requires professional judgment about what is disproportionate in that person's circumstances. Review of diagnostic validity.
DSM-5-TR severity specifiers distinguish mild, moderate, and severe presentations using the number of criterion-B psychological or behavioral features and, in severe cases, symptom multiplicity or marked severity. The DSM-5-TR also recognizes a predominantly painful presentation and a persistent course. These specifiers are not simply measures of physical disease severity. They describe clinical aspects of the SSD diagnosis, and their agreement between raters is still an active research issue. Scoping review.
What is bodily distress disorder in ICD-11?
Bodily distress disorder is ICD-11 code 6C20, within Disorders of Bodily Distress or Bodily Experience. Its central elements are persistent bodily symptoms that are distressing and become the focus of excessive attention, with significant impairment in personal, family, social, educational, occupational, or other important functioning. The symptoms and associated attention typically last several months; ICD-11 guidance describes three months or more as an example. The ICD-11 system specifies mild, moderate, and severe BDD under codes 6C20.0, 6C20.1, and 6C20.2, respectively. WHO clinical descriptions and diagnostic requirements.
Excessive attention may manifest as extensive symptom preoccupation, persistent focus despite appropriate clinical assessment or explanation, repeated healthcare consultations, or other forms of difficulty disengaging from symptoms. Specific healthcare behavior must be understood in context: a person facing access barriers might be highly preoccupied without repeated visits, while an individual with poorly investigated symptoms might need multiple appropriate consultations. The aim is an informed clinical evaluation, not a numerical quota of appointments. WHO guidance; comparative criteria study.
When a medical disease is established, ICD-11 directs clinicians to judge whether the symptom-related attention is clearly excessive in relation to the nature and severity of that condition. BDD also requires that the symptoms, distress, and preoccupation are not better accounted for by another mental disorder. For instance, predominantly illness-related obsessions, panic attacks, depressive episodes, or generalized worry can call for a different primary formulation. The presence of more than one disorder remains possible when each is clinically supported. Gureje et al., 2025.
DSM-5-TR SSD vs ICD-11 BDD: exact areas of similarity and difference
1. Symptom burden
Both require clinically important physical symptoms. SSD specifies one or more distressing symptoms or symptoms that disrupt everyday life. BDD specifies persistent distressing bodily symptoms with excessive attention and clinically meaningful impairment. Neither requires a preset count of separate affected organ systems, and both deliberately move away from using medically unexplained symptoms as the core diagnostic criterion. A patient's symptom severity alone does not establish either diagnosis. APA definition; WHO.
2. Psychological and behavioral requirements
SSD's DSM criterion B enumerates three partially overlapping domains: beliefs about symptom seriousness, persistent elevated anxiety, and excessive time or energy devoted to symptoms. A single domain can satisfy that component if the full criteria and clinical thresholds are present. ICD-11 BDD foregrounds excessive attention and ongoing preoccupation, with healthcare contact and response to reassurance among examples. The concepts are related but are not word-for-word or threshold-for-threshold equivalents. Comparative research.
3. Duration
DSM-5-TR describes a persistent symptomatic state typically lasting more than six months, allowing symptoms themselves to change over that interval. ICD-11 describes symptoms lasting several months, with three months or more as a clinical example. Neither duration statement supplies an independent self-diagnostic test. The full symptom, attention, distress, impairment, and differential requirements still apply. Diagnostic comparison.
4. Distress and functional impairment
For SSD, distressing physical symptoms or significant disruption of daily life satisfy the somatic symptom component, alongside the remaining requirements. For ICD-11 BDD, the symptoms are distressing and significant impairment in important areas of functioning is required. This more explicit joint distress-and-impairment rule can yield a different case threshold. The difference is clinically meaningful even when a person's underlying bodily symptoms are identical. Gureje et al..
5. Medical reassurance and care seeking
For BDD, persistent symptom focus despite appropriate clinical examination, investigations, or explanation can help establish excessive attention. Repeated contacts may be an expression of that attention. DSM SSD does not require healthcare visits or a failure to respond to reassurance. In either system, contact patterns require consideration of clinical uncertainty, medical access, cost, disability, and quality of previous evaluations. Patients are entitled to seek assessment for medically relevant changes. International epidemiological comparison.
6. Other mental disorders
ICD-11 BDD contains a specific instruction to avoid using the label when another mental disorder better accounts for the physical symptoms and associated distress or preoccupation. DSM SSD does not express the same general exclusion rule in its criteria, although good DSM assessment also examines comorbidity and alternative explanations. This distinction affects crosswalks, especially with anxiety, depression, and health-focused obsessive-compulsive presentations. Gureje et al..
7. Severity and coding
Both systems use mild, moderate, and severe descriptors, but the meaning of those descriptors follows each system's own rules. Matching names do not prove matching severity cutoffs. ICD-11 BDD uses the 6C20 code family, whereas DSM diagnoses may be paired with jurisdiction-specific coding systems for administrative purposes. Clinical categories, national billing systems, and research algorithms should be documented separately. WHO CDDR; DSM resource.
Why a direct diagnostic crosswalk requires clinical reassessment
Older DSM-IV and ICD-10 somatoform diagnoses often depended on a contested distinction between explained and unexplained bodily symptoms. That approach was difficult to apply consistently because medicine changes, multiple conditions coexist, investigations differ by setting, and symptom causation may remain uncertain. Newer DSM and ICD frameworks emphasize the additional psychological, attentional, behavioral, and disability-related characteristics of a clinically important syndrome. The resulting diagnoses share a rationale without being identical. Löwe et al., The Lancet, 2024; SSD evidence review.
A patient can satisfy both sets of criteria if there is persistent and distressing symptom burden, clinically excessive attention, and the required impairment and duration. Another patient can meet SSD but lack clear evidence of the additional ICD-11 impairment threshold, or have symptoms and concern that are better explained under ICD-11 by another mental disorder. A third person can meet BDD during a period described as several months while still requiring longitudinal evaluation of the DSM-5-TR duration formulation. These are classification examples, not diagnoses of hypothetical individuals.
Researchers who pool SSD and BDD without indicating the actual entry criteria can obscure differences in symptom burden, healthcare access, severity, comorbidity, and treatment response. Studies should identify the diagnostic manual and version, clinical interview procedures, whether medical comorbidities were evaluated, and the exact measures used. European outcome-domain recommendations.
What 18,105 participants in a 2025 study revealed
An important cross-system investigation in World Psychiatry analyzed representative adult household samples in Hong Kong, the Philippines, and Qatar, totaling 18,105 respondents. Based on standardized interview operationalizations, pooled point prevalence was 2.0% for ICD-11 BDD, 3.5% for DSM-5 SSD, 4.1% for at least one condition, and 1.4% for both. Consequently, 0.6% were classified with BDD only and 2.1% with SSD only. These figures demonstrate strong overlap along with material non-equivalence. They are estimates for these three settings, not a global census or an individual's diagnostic probability. Gureje et al., 2025.
The same analysis found that BDD-only respondents experienced an adjusted mean of 4.7 health-related days completely unable to fulfill usual roles in the previous month; the SSD-only mean was 3.1. Associations with anxiety and mood disorders, PTSD, and selected chronic physical conditions were common, although their magnitude differed. These are associations, not proof that a person's symptoms are caused by mental illness or past trauma. The comparison across subgroups was more complicated than a single severity ranking. Original study.
The study also has limitations relevant to clinical interpretation. Its cross-sectional design precludes causal inference. Survey administration differed between settings and the combined response rate was limited. Importantly, the team deliberately did not operationalize the ICD-11 condition requiring the presentation not to be better accounted for by another mental disorder, in order to study psychiatric associations. Therefore the resulting BDD estimates are not identical to an expert applying every CDDR requirement during an individualized clinical examination. Methods and limitations.
Earlier high estimates from brief self-report screening do not automatically conflict with these interview-based rates. A scoping review of SSD studies described a mean population proxy frequency around 12.9%, while warning that many estimates lacked criterion-standard diagnostic interviews. Screening thresholds, interview diagnoses, and medical case ascertainment measure related but different phenomena. SSD scoping review.
How SSD and BDD are assessed in clinical practice
Medical history and examination
The clinician documents specific symptoms, onset, variation, associated signs, activity limitation, prior diagnoses, medications, substance exposure, infections, injuries, and previous tests. The examination and any further investigations should be selected using symptoms, physical findings, risk factors, and relevant medical standards. Appropriate assessment remains important in patients who already carry a functional or somatic-distress diagnosis. New symptoms and materially changed findings can warrant new medical evaluation. The Lancet clinical review.
A normal scan, negative laboratory test, or absence of a demonstrated lesion is not a positive diagnostic criterion for SSD or BDD. Similarly, frequent specialist consultations are not themselves evidence of psychopathology. The clinician must find the actual diagnostic features specified by the chosen classification while maintaining an independent assessment of medical illness. The aim is to support a coherent explanation and plan, not to stop considering physical health after a psychiatric label is applied. APA; WHO.
Thoughts, emotions, behaviors, and attention
Clinicians explore the meaning assigned to bodily sensations, persistent fear about their seriousness, attention devoted to symptoms, time spent monitoring the body, requests for reassurance, avoidance of activity, and effects on daily life. They also ask about understanding of an existing disease and whether previous medical explanations were adequate. A patient undergoing a genuinely dangerous change in medical condition may respond with appropriate fear. Excessiveness is a clinical judgment relative to the entire situation, not a simple adjective attached to distressed behavior. Review of persistent physical symptoms.
Duration, distress, impairment, and alternative explanations
The same interview should assess work, family, social activities, education, independence, emotional distress, and time course. DSM-5-TR requires careful examination of the criterion-B domains. ICD-11 also calls for the distinct impairment threshold and a determination that another disorder does not better account for the clinical pattern. Comorbid depression, anxiety, chronic pain, or other medical disorders can complicate interpretation and deserve assessment in their own right. Gureje et al..
Screening questionnaires and their limits
The Somatic Symptom Scale-8 and Patient Health Questionnaire-15 quantify physical symptom burden; the SSD-12 addresses cognitive, emotional, and behavioral components. These tools do not independently verify every DSM-5-TR or ICD-11 requirement. A scoping review published October 9, 2026 evaluated 34 studies and 19 instruments, reporting that only three were specifically developed for SSD and that instruments differed substantially in criterion coverage. Li, Huang, and Quan, 2026.
A 2026 study of the newly developed Bodily Distress Inventory reported encouraging initial psychometric properties in a trauma-exposed general population sample, while identifying the need for validation in other groups. That is early instrument evidence, not a universal diagnostic standard or proof that a questionnaire can automatically translate SSD into BDD. A high score is a screening or research observation, not a clinical diagnosis. BoDI validation study.
Differential diagnosis and major conceptual boundaries
Physical illness, persistent physical symptoms, and chronic pain
A person may have diabetes, inflammatory disease, arthritis, migraine, endometriosis, gastrointestinal illness, cardiac disease, chronic pain, or another clinically significant illness and also experience severe symptom-related distress. Physical treatment and medical monitoring continue according to that condition's needs. The separate question is whether the additional DSM or ICD criteria are met. Persistent physical symptoms is a descriptive umbrella term regardless of the cause, and it cannot be substituted for a specific psychiatric diagnosis. Löwe et al..
Functional somatic disorder and bodily distress syndrome are additional concepts found in the literature, each with particular proposed or studied criteria. Bodily distress syndrome (BDS) is not synonymous with ICD-11 bodily distress disorder (BDD). The acronym overlap is a frequent cause of misleading comparisons. Researchers have proposed a broader functional somatic disorder framework without requiring the same psychiatric features; that proposal cannot silently replace established DSM-5-TR or ICD-11 rules. Classification discussion paper.
Health anxiety and illness anxiety disorder
Health anxiety can describe ordinary worry or clinically significant concern. DSM-5-TR illness anxiety disorder generally centers on fear of having or developing severe illness when somatic symptoms are absent or mild. SSD centers on substantive distressing physical symptoms with disproportionate thoughts, feelings, or behaviors associated with them. ICD-11 BDD demands assessment of excessive symptom-related attention and disability in its framework. See Illness Anxiety Disorder: Symptoms, Diagnosis, and Treatment and Health Anxiety: Signs, Triggers, and When It Becomes a Disorder.
OCD, generalized anxiety, panic, and depression
Somatic obsessions, reassurance rituals, panic-related bodily sensations, generalized worry, and depression-associated pain or fatigue can overlap at the symptom level. Their differential assessment concerns the full pattern: intrusive obsessions and compulsions, discrete panic episodes, pervasive worry, mood symptoms, and function. ICD-11 explicitly asks if an alternative mental disorder better accounts for the bodily distress. Co-occurring disorders may also be present and require their own care. See OCD vs Illness Anxiety Disorder.
Functional neurological disorder and seizures
Functional neurological disorder involves neurologically framed changes in movement, sensation, awareness, speech, or other functions. Its assessment relies on appropriate neurological investigation and positive examination findings where available; it is not defined solely by normal structural imaging. Functional seizures must be distinguished from epilepsy, while recognizing that both can coexist. Neither SSD nor BDD serves as a shortcut to diagnose FND or explain seizure-like episodes. Functional Neurological Disorder Diagnosis: Positive Signs and Medical Assessment.
Trauma, dissociation, and causal hypotheses
Trauma exposure, stress, anxiety, and depression can be associated with somatic distress in population studies. Such associations do not show that trauma is a necessary cause, establish an individual's symptom mechanism, or imply hidden psychological content. Neither DSM SSD nor ICD-11 BDD requires a history of trauma. Research considers interacting biological, perceptual, psychological, and social factors, with uncertainty about their importance in a particular person. The Lancet synthesis; population associations.
Factitious disorder and malingering
Factitious disorder involves evidence of deliberate falsification or induction of symptoms together with identified deception; malingering refers to intentional misrepresentation in pursuit of external incentives and is not itself a DSM mental disorder. SSD and BDD do not involve an assumption of intentional production, fraud, or malingering. Symptom inconsistency, repeated requests for tests, or frustration in the clinical encounter cannot establish deception. See Factitious Disorder: Symptoms, Assessment, and Treatment.
Illustrative clinical scenarios
A person with a diagnosed inflammatory condition continues to experience severe pain and monitors every sensation with substantial anxiety. Appropriate assessment of disease activity comes first. Depending on the degree of symptom-related preoccupation, the duration, distress, functioning, and alternative explanations, an additional SSD or BDD diagnosis might or might not be appropriate. The physical illness remains clinically relevant in every case.
A person has experienced fatigue, dizziness, and chest discomfort for several months, and the symptoms increasingly interfere with work and relationships. The clinician evaluates potential cardiac, autonomic, sleep, endocrine, medication-related, and other medical contributors, together with symptom-related thought patterns and activity. A review under ICD-11 and DSM-5-TR can yield different outcomes because each uses its own threshold and time course. The case cannot be assigned a diagnosis from duration alone.
A person fears a severe disease but reports few physical symptoms and mainly performs repeated mental checking and reassurance-seeking. The dominant concern may warrant assessment for health anxiety, illness anxiety disorder, OCD, or another condition. The presence of fear does not automatically satisfy the bodily symptom requirement of SSD or the full BDD formulation. These examples explain differential reasoning and do not serve as self-diagnostic algorithms.
Treatment and coordinated care
Assessment and treatment should be person-centered. Clinicians validate the reality of symptoms, explain how different components of suffering may interact, treat known medical diseases, identify functional goals, and agree on follow-up for changing symptoms. Coordinated primary care, specialist, and psychological care can reduce fragmented explanations and unnecessary repetition without restricting appropriate investigation. An effective plan respects the patient's experience and clarifies precisely when to seek reassessment. Clinical review, 2024.
Cognitive behavioral therapy may help people work with catastrophic interpretations, repetitive checking, symptom-focused attention, avoidance, and loss of valued activities. Acceptance- and mindfulness-based interventions can support functioning and distress regulation in suitable cases. A 2025 network meta-analysis of 74 studies involving 8,277 participants found benefits of both CBT and acceptance/mindfulness approaches for somatic symptom severity compared with waitlist controls. The research pooled several bodily-distress and functional-syndrome definitions, so it does not prove identical effects among strictly diagnosed DSM-5-TR SSD and ICD-11 BDD cohorts. Maas genannt Bermpohl and Martin, 2025.
A 2026 meta-analysis of 23 randomized trials reported benefits of internet-based CBT for several somatic and health-anxiety outcomes across SSD and related functional conditions. Relative effects differed according to the comparator and symptom domain. Digital therapy may improve access for some patients, but program quality, safety assessment, clinical support, accessibility, and coexisting medical conditions determine its suitability. Trials involving functional syndromes do not automatically establish specific treatment efficacy for the stricter ICD-11 BDD construct. Liu et al., 2026.
Medication is individualized to identifiable indications, including co-occurring depression, anxiety conditions, sleep disturbances, or medical pain syndromes. The diagnostic label by itself is not a mandate for a particular drug. Rehabilitation, occupational support, pacing, activity planning, and educational accommodations may help restore functioning, but must be adjusted to the person's actual physical illness and capabilities. Patients should not discontinue prescribed medication merely because they receive a somatic-distress diagnosis. The Lancet review.
Long-term outcomes and practical meaning of different labels
The diagnostic label may change when a patient moves between countries, healthcare settings, or research protocols, even though the symptom experience remains similar. Accurate records should identify the classification system and version, features supporting the diagnosis, medical conditions separately present, time course, and outstanding clinical questions. It is better to document the evidence for a diagnosis than to assume that translating the name preserves its meaning.
Prognosis depends on the clinical presentation, medical illness, symptom duration, distress, functioning, support, and treatment response. Improvement may involve more activity, less fear, better coordination of care, and improved quality of life even if physical symptoms remain. Population averages and cross-sectional studies cannot predict a particular person's course. Ongoing medical evaluation remains appropriate when the symptom pattern changes or new findings arise. Persistent physical symptoms review.
Children, adolescents, and cultural interpretation
In children and adolescents, developmental communication, pediatric illness, family responses, peer life, school attendance, and caregivers' accounts are important. A young person with persistent symptoms needs appropriate medical evaluation and an assessment of functioning and emotional distress suited to their developmental stage. Adult survey rates and adult questionnaires cannot automatically be transferred to pediatric populations. Schools may need to provide accommodations while evaluation and treatment continue. WHO CDDR; diagnostic evidence review.
Culture, access to healthcare, disability, socioeconomic stressors, and language influence what symptoms mean to a person and how they seek assistance. The 2025 comparative study reported variations among Hong Kong, the Philippines, and Qatar. In a setting with poor access, a lack of repeated visits does not demonstrate lack of preoccupation; in a setting with fragmented care, many visits may be an appropriate attempt to obtain evaluation. Diagnostic excessiveness cannot be inferred from cultural stereotypes or appointment counts. Gureje et al..
What the scientific evidence still cannot establish
The reliability and usefulness of new diagnostic constructs are supported by a growing but heterogeneous evidence base. A 2023 randomized field study involving 1,065 clinicians found that ICD-11 BDD guidance improved diagnostic accuracy over ICD-10 somatoform guidance when clinicians judged standardized vignettes. That is useful evidence about classification, but vignette performance is not the same as diagnosing medically complex individuals and does not prove superiority over DSM-5-TR. Case-controlled field study.
Open research questions include the stability of diagnoses over years, the best methods for distinguishing proportional medical vigilance from harmful overattention, differences across cultures, the consequences of diagnostic disagreement, and which treatments are most effective within rigorously defined ICD-11 BDD versus DSM-5-TR SSD groups. The 2026 screening review and early BoDI validation improve measurement options but do not produce a universal laboratory test or one-to-one crosswalk. Li et al.; BoDI study.
Observed associations among bodily distress, autonomic changes, symptom learning, stress, trauma, depression, and other factors support multifactorial research programs. Their causal contribution varies and is not established for an individual merely by meeting a diagnostic classification. Clinical care benefits from explaining what is known, what remains uncertain, and how necessary medical reassessment will occur. Löwe et al..
Questions to ask a clinician
Useful questions include: Which manual and version are you using? Which features establish excessive thoughts, feelings, behavior, or attention? How were duration, distress, and functional impairment measured? How do my known physical illnesses change the assessment? Were illness anxiety, mood disorder, panic, OCD, or neurological conditions considered? What findings would lead to further medical review? What goals will treatment pursue, and how will progress be measured? An informed clinician can explain a diagnosis in terms specific to the patient rather than relying on vague labels.
Severe new chest pain, serious breathing problems, fainting, sudden neurological deficits, significant changes in consciousness, or other potentially urgent symptoms require appropriate immediate medical evaluation. An existing SSD or BDD diagnosis never invalidates warning signs. If distress escalates to hopelessness or self-harm thoughts, timely professional help is also important.
Frequently asked questions
Are SSD and ICD-11 BDD identical?
No. They overlap but differ in duration formulation, distress and impairment thresholds, symptom-related attention and behavioral examples, and the ICD-11 better-accounted-for requirement. A diagnosis under one manual is not an automatic diagnosis under the other. Gureje et al., 2025.
Can either disorder occur alongside a diagnosed medical illness?
Yes. Physical illness and somatic-distress classification can coexist when all the relevant criteria are met. Appropriate concern about a serious illness should never be called excessive solely because someone seeks care. APA; WHO.
Do the diagnoses mean the symptoms are invented?
No. They refer to real symptoms, distress, and patterns of attention or response. Intentional symptom fabrication is a separate question requiring its own evidence. Neither SSD nor BDD establishes psychological causation. APA clinical definition.
Is three months enough for BDD and six months for SSD?
The ICD-11 wording describes persistence for several months, for example three months or more; DSM-5-TR describes a persistent symptomatic state typically longer than six months. In both cases clinicians assess the full syndrome, not the calendar alone. Comparative paper.
Is bodily distress syndrome the same as bodily distress disorder?
No. Bodily distress syndrome (BDS) is a separate research construct, while bodily distress disorder (BDD) is the specific ICD-11 6C20 diagnosis. The acronyms should never be swapped. Body dysmorphic disorder is another distinct concept. ICD-11; functional somatic classification research.
Does a negative medical test prove BDD or SSD?
No. Tests answer particular medical questions, while either clinical diagnosis requires its own affirmative symptom-related findings and attention to differential diagnoses. New or changed medical findings still require proper evaluation. The Lancet.
Can one person satisfy both classifications?
Yes. In the three-setting 2025 survey, 1.4% met both operational definitions; 0.6% met BDD alone and 2.1% SSD alone. This demonstrates overlap and non-equivalence, not the probability for any particular patient. World Psychiatry study.
Which diagnosis is more serious?
Neither label automatically ranks individual severity. Each has its own criteria and severity specifiers. Population findings on disability cannot determine an individual's needs or prognosis. Comparative analysis.
Do both diagnoses have the same treatment?
Evidence supports individualized, coordinated medical care and psychological interventions for some patients with bodily distress, including CBT. Many trials use mixed older diagnostic categories and related functional syndromes; exact head-to-head intervention evidence for strictly defined DSM SSD and ICD-11 BDD remains limited. 2025 network meta-analysis; 2026 digital CBT meta-analysis.
What if my record changes from SSD to BDD?
Ask which manual is now being used, which criteria were independently established, and how medical diagnoses and ongoing follow-up are preserved. The label can change because the classification framework changes without any immediate change in bodily symptoms.
Related Articles
Explore Somatic Symptom and Functional Disorders: Types, Diagnosis, and Treatment, Somatic Symptom Disorder: Symptoms, Diagnosis, and Treatment, Bodily Distress Disorder (ICD-11): Symptoms, Criteria, and Treatment, and Somatization: Meaning, Symptoms, and Modern Clinical Terminology. These published English pages cover related, distinct search questions.
References
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Publisher and DSM resources.
American Psychological Association. (2023). Somatic symptom disorder. APA Dictionary of Psychology. Definition.
Gureje, O., De Guzman, M. L. R., Khaled, S. M., et al. (2025). The epidemiology of ICD-11 bodily distress disorder and DSM-5 somatic symptom disorder in new large-scale population surveys within the World Mental Health Survey Initiative. World Psychiatry, 24, 395–403. DOI: 10.1002/wps.21353.
Li, X.-x., Huang, Z.-p., & Quan, K.-j. (2026). Screening instruments for somatic symptom disorder: A scoping review of development, validation, and cross-cultural adaptation. BMC Psychology. DOI: 10.1186/s40359-026-05691-z.
Liu, S., Li, Y., He, Z., Sima, X., & Li, J. (2026). Efficacy of internet-based cognitive behavioral therapy on somatic symptom disorder and common related functional disorders: A meta-analysis of randomized controlled trials. General Hospital Psychiatry, 99, 92–101. DOI: 10.1016/j.genhosppsych.2026.01.017.
Löwe, B., Toussaint, A., Rosmalen, J. G. M., et al. (2024). Persistent physical symptoms: Definition, genesis, and management. The Lancet, 403, 2649–2662. DOI: 10.1016/S0140-6736(24)00623-8.
Löwe, B., et al. (2022). Somatic symptom disorder: A scoping review on the empirical evidence of a new diagnosis. Psychological Medicine. Full text.
Maas genannt Bermpohl, F., & Martin, A. (2025). Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress: A network meta-analysis. Psychotherapy and Psychosomatics, 94, 207–224. DOI: 10.1159/000544825.
Rief, W., Burton, C., Frostholm, L., et al. (2017). Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: EURONET-SOMA recommendations. Psychosomatic Medicine. DOI: 10.1097/PSY.0000000000000502.
Rosmalen, J. G. M., et al. (2020). Functional somatic disorders: Discussion paper for a new common classification for research and clinical use. Journal of Psychosomatic Research. PubMed.
Shevlin, M., et al. (2026). Measuring ICD-11 bodily distress disorder symptoms: Development and initial validation of the bodily distress inventory. Journal of Psychiatric Research. DOI: 10.1016/j.jpsychires.2026.03.020.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official publication.
World Health Organization Global Clinical Practice Network investigators. (2023). Case-controlled field study of the ICD-11 clinical descriptions and diagnostic requirements for bodily distress disorders. Journal of Affective Disorders, 333, 271–277. PubMed.